Illuminant Presents at CNS 2023

We are so proud of our team for representing Illuminant at CNS 2023 in Washington, D.C. earlier this month!

Our Chief Clinical Officer, Ikaasa Suri, conducted an oral presentation during the Spine session where she discussed the difference in clinical outcomes between 3D navigation and 2D fluoroscopy. We found that while 3D navigation has a nearly 6.5% greater surgical success rate than 2D fluoroscopy, there still exists room to improve 3D navigation tools – particularly with respect to their lengthy setup processes and radiation exposure.

We also had the opportunity to present on another project led by Ikaasa and research associate, Mehr Suri, that analyzed the spinal case volumes required a in-patient facilities to justify the purchase of commercialized 3D navigation products. We found that systems are currently too expensive and that current pricing structures disincentivize at least 61% of all in-patient hospitals in the US from purchasing the product. At Illuminant, we are building the future of SNTs that will be easy to set up, intuitive to use, and affordable to purchase.

We also had the time to catch up with some of our advisors, including Dr. Matthew Carr who served as the Principle Investigator of our systematic review. Thank you to all of our other research associates who contributed to both projects and attended CNS with us, as well as the neurosurgeons who helped support our research!